Skip to main content
Signal8

Cao Sean Wuxiong

SEC insider (Form 3/4/5 filer). CIK 0002109966. Chief Bus. Development Officer at NovaBridge Biosciences (NBP). 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in ROCKVILLE, MD.

Companies Cao Sean Wuxiong has filed insider reports for

  • NovaBridge Biosciences (NBP): Officer, Chief Bus. Development Officer
Cao Sean Wuxiong profile photo

Cao Sean Wuxiong

CIK: 0002109966

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NovaBridge Biosciences logo
NBP

NovaBridge Biosciences

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • NovaBridge Biosciences logo
    NBP

    NovaBridge Biosciences

    Sep 9, 2026
    Sale
    Direct
    108K shares at avg. $0.74$80K
  • NovaBridge Biosciences logo
    NBP

    NovaBridge Biosciences

    Sep 3, 2026
    Exercise
    Direct
    235.1K shares-
  • NovaBridge Biosciences logo
    NBP

    NovaBridge Biosciences

    Sep 3, 2026
    Exercise
    Direct
    104.2K shares-
  • NovaBridge Biosciences logo
    NBP

    NovaBridge Biosciences

    Jun 22, 2026
    Award

    Restricted Share Units

    Direct
    181.3K shares-
  • NovaBridge Biosciences logo
    NBP

    NovaBridge Biosciences

    Jun 22, 2026
    Award

    2025 Employee Share Option (right to buy)

    Direct
    181.3K shares-
  • NovaBridge Biosciences logo
    NBP

    NovaBridge Biosciences

    May 14, 2026
    Sale
    Direct
    21.4K shares at avg. $1.99$43K

1-6 of 6